Molecular signatures define two main classes of meningiomas

Table 2 Patient Clinical Data of the 23 Profiled Meningiomas

	SF4271	SF4287	SF4316	SF4465	SF4881	SF4886	SF4894	SF4931	SF3072	SF3118	SF3363	SF3411	SF4151	SF2176	SF3622	SF2841	SF3476	SF3595	SF3693	SF3938	SF4005	SF4290	SF4457
Grade	BENIGN (GRADE 1)								ATYPICAL (GRADE 2)							MALIGNANT (GRADE 3)
Molecular Subgroup	LOW-PROLIFERATIVE												*	HIGH-PROLIFERATIVE
Embolized	No	Y	Y	No	No	No	No	Y	No	Y	No	Y	No	No	No	Y	Y	No	N	Y	Y	Y	No
Sex	F	F	F	F	F	F	F	F	F	F	F	F	F	F	M	F	F	F	F	F	M	F	F
Age	58	57	74	72	56	51	65	35	39	62	63	47	64	60	43	83	71	52	52	58	74	58	67
Location	C	C	C	S	C	C	S	S	C	C	I	s	S	C	F	T	T	C	C	C	C	C	C
Primary or Recurrent	P	P	P	P	P	P	P	P	P	P	P	P	P	P	P	P	P	R	R	P	P	P	R
Extent of Resection	G	G	Su	G	G	G	G	G	G	Su	G	G	G	G	G	Su	Su	Su	Su	G	G	G	G
Disease Status@2yr	NR	NR	R	NR	NR	NR	NR	NR	NR	NR	U	NR	D	NR	R	D	R	D	D	R	D	NR	D

F = Female; M = Male; C = Convexity; S = Skull Base; I = Intraventricular; s = spinal; F = Falx; T = Tentorium; P = Primary; R = Recurrent; G = Gross Total Resection; Su = Sub Total Resection; NR = Non-Recurrent; R = Recurrent; D = Dead; U = Unknown;* Refers to the Grade 2 meningioma that was an outlier

ISSN: 1476-4598